140
Participants
Start Date
November 7, 2024
Primary Completion Date
September 30, 2027
Study Completion Date
August 30, 2029
IMC-P115C
IV infusion
RECRUITING
Melanoma Institute Australia, Wollstonecraft
RECRUITING
Cancer Research South Australia (CRSA), Adelaide
RECRUITING
Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan
RECRUITING
Istituto Europeo di Oncologia, Milan
RECRUITING
Hospital Universitario Ramon y Cajal, Madrid
RECRUITING
START Madrid - Hospital Universitario Fundación Jiménez Díaz, Madrid
RECRUITING
Centre Hospitalier Universitaire (CHU) de Toulouse-Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), Toulouse
RECRUITING
UNICANCER - Centre Leon-Berard (CLB), Lyon
RECRUITING
"Istituto Nazionale Tumori IRCCS Fondazione G. Pascale", Napoli
RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Linear Clinical Research ltd., Nedlands
RECRUITING
Hospital Universitari Vall d Hebron, Barcelona
RECRUITING
Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals, Barcelona
Lead Sponsor
Immunocore Ltd
INDUSTRY